Adtalem Global Education (NYSE:CVSA) Upgraded at Zacks Research

Zacks Research upgraded shares of Adtalem Global Education (NYSE:CVSA) from a hold rating to a strong-buy rating in a report published on Tuesday,Zacks.com reports.

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock opened at $98.91 on Tuesday. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.37. Adtalem Global Education has a 12-month low of $86.26 and a 12-month high of $156.26. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of 12.38, a P/E/G ratio of 0.81 and a beta of 0.71.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.